Alaska Becomes Latest State To Regulate PBMs
Published by Inside Health Policy
This week Alaska became the latest state to require pharmacy benefit managers be licensed. The bill, which passed the legislature via unanimous consent earlier this year, also bans gag clauses and lays out guardrails for PBM audits of pharmacies.
“Big money lobbyists and the insurance companies they work for have fought for nearly a decade to prevent a bill like House Bill 240 from passing. We got this bill across the finish line this session because saving Alaskans money on health care costs is not a partisan issue, it’s an Alaskan issue,” state Rep. David Guttenberg (D) wrote in a press release announcing the signing on Tuesday (Aug. 4).
There are growing calls to regulate PBMs. More than 30 states introduced some form of PBM legislation in 2018, making it by far the most common drug-pricing legislation being pursued in the states.
And state legislators are getting help from national groups who are pushing for lower drug prices. The National Academy for State Health Policy released model PBM legislation in August that includes licensure requirements.
Others say legislation may not even be necessary. Drug pricing advocates recently urged a room of insurance commissioners to tackle drug pricing, including regulating PBMs, without legislation.
Alaska’s law requires PBMs to register as third-party administrators biennially. It does not, however, include a requirement that PBMs “exercise good faith and fair dealing,” like a bill awaiting California Governor Jerry Brown’s (D) signature. — Nicholas Florko (nflorko@iwpnews.com)
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.